The Alzheimer's Association announces our largest-ever annual research investment — granting more than $42 million to 162 scientific investigations. This represents a 40% increase over 2018 and brings the Association's current research investment to $167 million in more than 500 active best-of-field projects in 27 countries.
Fulfilling the Part the Cloud Challenge on Neuroinflammation, the Alzheimer's Association announces a $3 million grant to Longeveron LLC to advance to the company's adult stem cell Alzheimer's research.
Nearly 6,000 scientists attend the Alzheimer's Association International Conference® (AAIC®) in Los Angeles, where Zenith Society member Dagmar Dolby and her son David Dolby receive the Jerome H. Stone Philanthropy Award for Research.
A gift from Mary Barton Smith completes the Association's $800,000 funding commitment to the SPRINT MIND 2.0 Study. Principal investigator Jeff Williamson, M.D., (pictured) and team are investigating the impact of intensive blood pressure treatment on the risk of dementia.
Clay and Debbie Jones make their second Zenith-level investment, establishing the Tish Smith Alzheimer's Research Fund at the Alzheimer's Association.
NARFE (National Active and Retired Federal Employees Association) pledges $1 million for the International Research Grant Program. NARFE members have raised more than $13 million to sponsor Association research grants since 1985.
The Alzheimer's Association Zenith Society welcomes two new members who designate their gifts to support research: the Saltzman Family and an anonymous couple.
The Part the Cloud luncheon in Menlo Park, California, raises more than $1 million for the International Research Grant Program. Founded and chaired by Mikey Hoag (pictured with luncheon chairs Stephanie Harman and Heather Pietsch), the Part the Cloud movement has raised more than $30 million to advance clinical trials of experimental Alzheimer's disease treatments since 2012.
Bob Thistle (pictured with Rebecca Edelmayer, Ph.D.) joins the Alzheimer's Association Zenith Society, designating half of his leadership gift to support the Association's research mission.
California-based Mary Oakley Foundation joins the Alzheimer's Association Zenith Society, designating their gift to support the International Research Grant Program, as well as the LEADS and LEARN studies.
Texas-based Samuels Family Foundation joins the Alzheimer's Association Zenith Society, designating the majority of their gift to support the International Research Grant Program.
The Alzheimer's Association announces our largest-ever annual research commitment — granting nearly $30 million to 131 scientific investigations including 112 projects funded through the International Research Grant Program. These grants include five made as part of the Tau Pipeline Enabling Program (T-PEP.)
Alzheimer's Association President and CEO Harry Johns announces that Step Up the Pace achieved nearly $110 million in its first four years. Dick Kipper and John Beuerlein co-chaired the first phase of the initiative, in which nearly 140 donors, including individuals, corporations, foundations and organizations, made gifts ranging from $100,000 to $5 million to advance research with the Alzheimer's Association.
Researchers report promising preliminary results of the SPRINT MIND study at Alzheimer's Association International Conference® 2018. Trial findings provide the strongest evidence to date about reducing risk of mild cognitive impairment and dementia through the treatment of high blood pressure.
Zenith Society members Joan and Paul Rubschlager make their second Zenith-level commitment to advance research, supporting the U.S. POINTER study. Zenith Society members Vicky Patel and Mary Barton Smith make their own U.S. POINTER gifts shortly thereafter.
Led by Mikey Hoag, the Part the Cloud movement raises $11 million for the Association's research program via its April 28 gala in Menlo Park, California. Proceeds from the event bring Part the Cloud's fundraising total to more than $29 million since 2012.
Following a lead gift from the Jeanne N. Hunter Foundation, Lynda and Larry Jodsaas (pictured) invest in the Association-led U.S. POINTER study — which will test how a multidimensional lifestyle intervention may preserve cognitive function in at-risk older adults.
John and Linda Tracy join the Zenith Society with an unrestricted gift to support the Alzheimer's Association research program.
Carol-Ann O’Mack joins the Alzheimer’s Association Zenith Society with her philanthropic investment in research via the Step Up the Pace initiative.
In partnership with the Alzheimer’s Drug Discovery Foundation, the Alzheimer's Association awards $1.85 million to support a clinical trial of an investigational therapy that combines two existing drugs to target two distinct Alzheimer’s disease processes. Funding for Alzheimer’s Combination Therapy Opportunities (ACTO) was provided by Zenith Society members Ned Goodnow and the Pine Family Foundation, as well as by the Kahlert Family Foundation and Dennis Mullen.
The Alzheimer's Association announces an annual research commitment of more than $28 million to over 129 scientific investigations — a 101 percent increase over our 2014 commitment. Projects included 112 investigations funded through the International Research Grant Program.
Dan and Diane Riccio join the Alzheimer's Association Zenith Society with their philanthropic investment in research via the Step Up the Pace initiative.
Step Up the Pace co-chairs John Beuerlein and Dick Kipper announce that the initiative has raised $75 million to advance the Association's research priorities.
Researchers report promising interim findings from the IDEAS Study at the Alzheimer's Association International Conference® 2017. As a result of undergoing an amyloid PET brain scan, approximately 60 percent of nearly 4,000 participants enrolled in the study saw changes in medical management such as changes in drugs prescribed and reduced need for spinal taps and other diagnostic testing.
Edward Jones commits an additional $3.9 million to the Association’s research program.
John and Crystal Beuerlein, the Borman Family Foundation, James and Elizabeth McDonnell (pictured with Randall Bateman, M.D.), Mary Barton Smith and others give $2.6 million to enable the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) High-Dose Escalation Study. Researchers are now administering an increased dose of Solanezumab, an experimental drug that recent research indicates may have a greater impact on slowing the progression of the disease at a higher dose.
The Gelfand Family donates $500,000 to complete philanthropic funding for grants awarded as part of the Women’s Alzheimer’s Research Initiative and to support the International Research Grant Program via The Judy Fund, their family fund at the Alzheimer’s Association.
The Fred A. and Barbara M. Erb Family Foundation makes its second Zenith-level investment in the Association's Global Research Program.
Jim Hunter makes a Zenith Society-level gift to establish the Jeanne N. Hunter Alzheimer’s Research Fund at the Alzheimer’s Association in honor of his wife. In its first year, the Jeanne Hunter Fund supports the Association’s commitment to the Vascular Contributions to Dementia in APOE4 Carriers Study.
Zenith Society member the Pine Family Foundation makes a philanthropic investment to complete funding for Alzheimer’s Combination Therapy Opportunities (ACTO), an innovative new grant competition that is enabling a clinical trial of two or more FDA-approved medications taken simultaneously to delay, slow or prevent Alzheimer’s disease.
The Alzheimer's Association announces research commitments totaling nearly $25 million in 135-plus scientific investigations— a 77 percent increase over our 2014 total commitment. The International Research Grant Program more than doubled our awards to early-career investigators thanks to giving by Debbie and Clay Jones and other philanthropic partners.
The Alzheimer's Association announces $2.2 million in grants to nine research projects investigating the role of sex and gender in Alzheimer's disease — a new area of research. The grants are funded by gifts to the Women's Alzheimer's Research Initiative by John and Crystal Beuerlein, Michele and Lawrence Herbert, Debbie and Clay Jones, Carol-Ann O'Mack, Sigma Kappa Sorority and Dr. Ellen Yankellow.
The Association announces four $1 million grants to scientists conducting clinical trials that target brain inflammation as an innovative avenue for Alzheimer's disease therapy. The grants are funded by donors to the Part the Cloud Challenge on Neuroinflammation including Mikey Hoag and Dagmar Dolby.
Co-chairs John Beuerlein (pictured with Alzheimer's Association Chief Science Officer Maria Carrillo, Ph.D.) and Dick Kipper report that Step Up the Pace has passed the $50 million fundraising mark, with 87 philanthropic gifts of at least $100,000.
Cheryl Gross joins the Alzheimer's Association Zenith Society with her investment in research via the Step Up the Pace initiative.
The API Generation Program launches GeneMatch, a program that uses genetic testing (through free cheek swab kits) to match volunteers with opportunities to participate in Alzheimer's prevention trials. Funding for the Generation Program is being provided by the Fineberg Foundation, GHR Foundation and Ned Goodnow.
Founded and chaired by Mikey Hoag and generously supported by Dagmar Dolby, the Part the Cloudgala raises a record-breaking $10.8 million for the Alzheimer's Association research program — funding the Challenge on Neuroinflammation and bringing Part the Cloud's five-year fundraising total past $17 million.
The Alzheimer's Association announces a $4.3 million research grant to the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Next Generation (NexGen) — made possible by investments by Zenith Society members John and Crystal Beuerlein and Mary Barton Smith and the financial services firm Edward Jones. Adding new drug candidates to the trial could potentially speed up the identification of disease-modifying interventions.
Patient enrollment begins in Imaging Dementia – Evidence for Amyloid Scanning (IDEAS). Created and co-chaired by the Alzheimer’s Association, IDEAS has received philanthropic investments from The Kahlert Foundation and the Pelletier Family Foundation.
The Alzheimer's Association announces a historic partnership with St. Louis-based financial services firm Edward Jones. The firm's commitment to the Association's mission includes $2.6 million for the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Next Generation (NexGen) study, led by Dr. Randall Bateman of Washington University in St. Louis.
John and Crystal Beuerlein make a Zenith Society-level investment in Step Up the Pace's Global Innovation Fund. They later designate their gift to support the DIAN-TU NexGen study, the International Research Grant Program, the Vascular Contributions to Dementia in APOE4 Carriers Study and the Women's Alzheimer's Research Initiative.
Zenith Society member Mary Barton Smith makes her third Zenith Society-level commitment — investing in the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Next Generation (NexGen). DIAN-TU is testing whether experimental medications can prevent Alzheimer's in people who have a 50/50 chance of inheriting a gene mutation that causes the disease by middle age.
The Alzheimer's Association announces commitments totaling more than $17 million in 80-plus scientific investigations for fiscal year 2015.
Ned Goodnow makes a Zenith Society-level investment in Step Up the Pace's Global Innovation Fund. He later designates his gift to the API Generation Study, Alzheimer’s Combination Therapy Opportunities (ACTO) and the Vascular Contributions to Dementia in APOE4 Carriers Study.
The Anne and Henry Zarrow Foundation invests $5 million in the Association's Zenith Fellows Awards — the largest gift to the program to date. The Zenith Fellows Awards are the most prestigious grants in the International Research Grant Program.
GHR Foundation partners with the Association and FBRI to invest $10 million to expand the API Generation Program, which includes two clinical trials testing whether drugs can prevent or delay dementia symptoms in people at elevated genetic risk of developing Alzheimer's at older ages. The foundation previously invested in LEARN.
Dick and Marianne Kipper make a Zenith Society-level investment in Step Up the Pace’s Global Innovation Fund, later designating their gift to enhance the pioneering Vascular Contributions to Dementia in APOE4 Carriers study.
An anonymous donor makes a $2.3 million gift to complete philanthropic funding of the Association's $8 million commitment to the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN), a first-of-its-kind study to identify the earliest signs of Alzheimer's and its risk factors.